• Publications
  • Influence
Advanced glycation end products cause epithelial-myofibroblast transdifferentiation via the receptor for advanced glycation end products (RAGE).
Tubulointerstitial disease, a prominent phenomenon in diabetic nephropathy, correlates with decline in renal function. The underlying pathogenic link between chronic hyperglycemia and the developmentExpand
  • 395
  • 19
  • PDF
Increased renal expression of vascular endothelial growth factor (VEGF) and its receptor VEGFR-2 in experimental diabetes.
It has been suggested that the cytokine vascular endothelial growth factor (VEGF) has an important role in the pathogenesis of diabetic retinopathy, but its role in nephropathy has not been clearlyExpand
  • 440
  • 12
Inactivation of the acid labile subunit gene in mice results in mild retardation of postnatal growth despite profound disruptions in the circulating insulin-like growth factor system.
Insulin-like growth factors (IGFs) I and II are important regulators of cell proliferation and differentiation. After birth, plasma IGFs, representing mostly liver-derived IGFs, circulate in ternaryExpand
  • 152
  • 11
  • PDF
Insulin-like growth factor binding protein-2 binding to extracellular matrix plays a critical role in neuroblastoma cell proliferation, migration, and invasion.
IGF binding proteins (IGFBPs) modulate IGF cellular bioavailability and may directly regulate tumor growth and invasion. We have previously shown that IGFBP-2 binds and localizes IGF-I to theExpand
  • 117
  • 10
Endothelial cells and the IGF system.
  • L. Bach
  • Biology, Medicine
  • Journal of molecular endocrinology
  • 28 October 2014
Endothelial cells line blood vessels and modulate vascular tone, thrombosis, inflammatory responses and new vessel formation. They are implicated in many disease processes including atherosclerosisExpand
  • 102
  • 8
  • PDF
IGF-binding proteins – the pieces are falling into place
The six insulin-like growth factor (IGF)-binding proteins (IGFBPs) are important regulators of IGF actions. IGF-independent actions of several IGFBPs have also been described. IGFBPs contain highlyExpand
  • 149
  • 7
Insulin-like growth factor binding protein-6: the "forgotten" binding protein?
  • L. Bach
  • Chemistry, Medicine
  • Hormone and metabolic research = Hormon- und…
  • 1999
Insulin-like growth factor binding protein-6 (IGFBP-6) differs from IGFBPs 1-5 in that it binds IGF-II with marked preferential affinity over IGF-I. Human and rat IGFBP-6 lack 2 and 4 N-terminalExpand
  • 95
  • 6
The N-terminal Disulfide Linkages of Human Insulin-like Growth Factor-binding Protein-6 (hIGFBP-6) and hIGFBP-1 Are Different as Determined by Mass Spectrometry*
The actions of insulin-like growth factors (IGFs) are modulated by a family of six high affinity binding proteins (IGFBPs 1–6). IGFBP-6 differs from other IGFBPs in having the highest affinity forExpand
  • 75
  • 5
Insulin-like growth factors and kidney disease.
  • L. Bach, L. Hale
  • Biology, Medicine
  • American journal of kidney diseases : the…
  • 1 February 2015
Insulin-like growth factors (IGF-1 and IGF-2) are necessary for normal growth and development. They are related structurally to proinsulin and promote cell proliferation, differentiation, andExpand
  • 57
  • 5
Reduced bone mass in daughters of women with osteoporosis.
To determine whether premenopausal daughters of women with postmenopausal osteoporosis have lower bone mass than other women of the same age, we measured the bone mineral content of the lumbar spineExpand
  • 328
  • 4